secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001295947-22-000020
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Q1 FY2023 revenue $277.1M, EPS $1.09, reaffirms full-year guidance
---------------------------------------------------------------------------

- Revenue $277.1M, +2.9% YoY; organic revenue (ex-Akorn, FX) declined 1.2%.
- Diluted EPS $1.09 vs $1.14 prior year, but ahead of internal expectations.
- Net cash from operations $58.2M; Non-GAAP free cash flow $57.2M.
- Reaffirmed FY2023 guidance: revenue $1.12-1.13B, EPS $4.18-4.23, FCF >=$260M.
- North American OTC flat at $242.5M; International OTC record $34.5M (+28.9%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594722000020/0001295947-22-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594722000020/pbh-20220804.htm
  HTML page:      https://secwatch.observer/filing/0001295947-22-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer